HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"count": 380,
"next": null,
"previous": "http://api.gregory-ms.com/trials/source/12/?page=37",
"results": [
{
"title": "Ocrelizumab Access by Socio-Economic Status",
"summary": "<b>Condition</b>: Multiple Sclerosis<br/><b>Intervention</b>: Drug: Ocrelizumab<br/><b>Sponsors</b>: Brigham and Women's Hospital; Genentech, Inc.; Boston Medical Center<br/><b>Not yet recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05131984?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2021-11-23T17:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2021-11-23T15:17:43Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "Improving Prospective Memory Via Telehealth",
"summary": "<b>Condition</b>: Multiple Sclerosis<br/><b>Interventions</b>: Behavioral: Prospective Memory Intervention; Behavioral: Educational<br/><b>Sponsor</b>: Saint Francis Care<br/><b>Recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05129293?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2021-11-22T17:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2021-11-22T13:57:43Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "An Individualized-health eLibrary App for People With Multiple Sclerosis",
"summary": "<b>Condition</b>: Multiple Sclerosis<br/><b>Intervention</b>: Device: SavvyHealth<br/><b>Sponsor</b>: University of Illinois at Urbana-Champaign<br/><b>Recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05124600?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2021-11-18T17:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2021-11-18T18:07:42Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "A Health Action Process Approach Online Intervention for People With Multiple Sclerosis",
"summary": "<b>Condition</b>: Multiple Sclerosis<br/><b>Intervention</b>: Behavioral: MSPA eClass<br/><b>Sponsor</b>: University of Illinois at Urbana-Champaign<br/><b>Recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05124522?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2021-11-18T17:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2021-11-18T18:07:42Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "Longitudinal Assessment of Iron Rims in MS Lesions",
"summary": "<b>Condition</b>: Multiple Sclerosis<br/><b>Interventions</b>: Biological: Blood sample provided; Diagnostic Test: 7-T MRI scan<br/><b>Sponsors</b>: Nottingham University Hospitals NHS Trust; Johns Hopkins University<br/><b>Not yet recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT05123443?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
"published_date": "2021-11-17T17:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2021-11-17T13:37:42Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "Cognition and HRQoL in Adults With Highly-active RMS in Year 3 and 4 After Initial Mavenclad® Dose (CLARIFY MS Extension)",
"summary": "<b>Condition</b>: Multiple Sclerosis<br/><b>Intervention</b>: Drug: Mavenclad®<br/><b>Sponsor</b>: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany<br/><b>Recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT04776213?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14",
"published_date": "2021-03-01T17:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2021-03-08T12:17:02Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations (SARS)",
"summary": "<b>Conditions</b>: SARS-CoV Infection; COVID-19; Allergic Reaction; Mast Cell Disorder; Non-atopic<br/><b>Interventions</b>: Biological: Moderna COVID-19 Vaccine; Biological: Pfizer-BioNTech COVID-19 Vaccine; Biological: Placebo<br/><b>Sponsors</b>: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network (ITN); Rho Federal Systems Division, Inc.<br/><b>Not yet recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT04761822?term=biontech&amp;sfpd_d=14&amp;sel_rss=new14",
"published_date": "2021-02-21T17:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2021-03-02T14:12:09Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "Antibody Response to COVID-19 Vaccines in Liver Disease Patients",
"summary": "<b>Condition</b>: Chronic Liver Disease<br/><b>Interventions</b>: Biological: BNT162b2; Biological: CoronaVac; Biological: AZD1222<br/><b>Sponsor</b>: Humanity & Health Medical Group Limited<br/><b>Not yet recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT04775069?term=biontech&amp;sfpd_d=14&amp;sel_rss=new14",
"published_date": "2021-03-01T17:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2021-01-03T01:00:00Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older",
"summary": "<b>Conditions</b>: SARS-CoV-2 Infection; COVID-19; Maternal Immunization<br/><b>Interventions</b>: Biological: BNT162b2; Other: Placebo<br/><b>Sponsors</b>: BioNTech SE; Pfizer<br/><b>Not yet recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT04754594?term=biontech&amp;sfpd_d=14&amp;sel_rss=new14",
"published_date": "2021-02-15T17:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2021-02-27T01:00:00Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
},
{
"title": "National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE)",
"summary": "<b>Condition</b>: SARS-CoV Infection<br/><b>Interventions</b>: Biological: COMIRNATY - BioNTech Manufacturing GmbH; Biological: COVID-19 Vaccine Moderna dispersion for injection - MODERNA BIOTECH; Biological: COVID-19 Vaccine AstraZeneca suspension for injection<br/><b>Sponsors</b>: Jens D Lundgren, MD; Ministry of the Interior and Health, Denmark<br/><b>Recruiting</b>",
"link": "https://clinicaltrials.gov/ct2/show/NCT04760132?term=biontech&amp;sfpd_d=14&amp;sel_rss=new14",
"published_date": "2021-02-18T17:00:00Z",
"source": "Clinical Trials.gov",
"publisher": null,
"container_title": null,
"relevant": null,
"ml_prediction_gnb": null,
"ml_prediction_lr": null,
"discovery_date": "2021-02-27T01:00:00Z",
"noun_phrases": null,
"doi": null,
"access": null,
"takeaways": null
}
]
}